The Canada-Africa Monkeypox Partnership (CAMP) is aimed at characterizing transmission dynamics and evaluating medical countermeasures to inform the clinical and public health response to m-pox. CAMP project is a twining study between Nigeria and Canada. This study is being jointly carried out by both countries.
CAMP Project
The Canada-Africa Monkeypox Partnership (CAMP) is aimed at characterizing transmission dynamics and evaluating medical countermeasures to inform the clinical and public health response to m-pox. CAMP project is a twining study between Nigeria and Canada. This study is being jointly carried out by both countries.
Project objectives in Nigeria include to:
- Characterize and compare Mpox transmission dynamics and serologic histories across epidemic contexts.
- Do formative research on readiness for trials of MPX therapeutics/vaccines in Nigeria and
- To determine MPX vaccine acceptability among adults in Nigeria
The Nigerian team comprises of four institutions that are collectively responsible for the implementation and attainment of the specific aims of the study. These are the Nigeria Institute of Medical Research (NIMR), Institute of Human Virology Nigeria (IHVN), Slum and Rural Health Initiative Nigeria (SRHIN), and the University of Ilorin (UNILORIN). Cohort 1 of the CAMP project is being implemented in Abuja, Bayelsa, Delta and Lagos States, while Cohort 2 is being implemented in Abuja and Lagos.
Amongst other things, understanding Mpox Transmission Dynamics in Nigeria should lead to the
- Development of targeted public health interventions that can lead to more effective prevention and control strategies, reducing the incidence of Mpox.
- Optimized diagnostic yield to enhance the capacity for early detection and surveillance of Mpox.
- Contributing to the scientific knowledge of the understanding of Mpox transmission in the Nigerian population and providing a foundation for future research on Mpox in Nigeria.
- Building local capacity and strengthening the healthcare infrastructure to better handle future outbreaks of Mpox and other infectious diseases.
- Community engagement and education efforts as part of the study to raise awareness about Mpox transmission, symptoms, and prevention
- Empowerment of At-Risk Populations, such as sexual gender minority communities, in the research process to actively participate in efforts to control and prevent Mpox thereby fostering a sense of ownership and responsibility.
Principal Investigator: Dr. Darrell Tan,
Co-Investigators: Dr. Evaezi Okpokoro, Dr. Ezenwa James Onyemata
Project Funders and collaborators: CIHR/IDRC
Project Duration: 2023-2024